LEVEL 4 B01AE06

Δραστικές

Φάρμακα

  • DRUGBANK - Bivalirudin
  • indication:

    For treatment of heparin-induced thrombocytopenia

  • pharmacology:

  • mechanism:

    Inhibits the action of thrombin by binding both to its catalytic site and to its anion-binding exosite.

  • toxicity:

  • absorprion:

  • halflife:

    25 min (in normal conditions)

  • roouteelimination:

    Angiomax is cleared from plasma by a combination of renal mechanisms and proteolytic cleavage

  • volumedistribution:

  • clearance:

    * 3.4 mL/min/kg [Normal renal function] * 3.4 mL/min/kg [mild renal function] * 2.7 mL/min/kg [moderate renal function] * 2.8 mL/min/kg [severe renal function] * 1 mL/min/kg [Dialysis-dependent patients]